Sumitomo Mitsui Trust Group
CRSP icon

Sumitomo Mitsui Trust Group’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$117M Sell
2,414,838
-125,051
-5% -$6.08M 0.07% 253
2025
Q1
$86.4M Sell
2,539,889
-205,787
-7% -$7M 0.06% 311
2024
Q4
$108M Sell
2,745,676
-222,358
-7% -$8.75M 0.07% 262
2024
Q3
$139M Sell
2,968,034
-183,480
-6% -$8.62M 0.1% 204
2024
Q2
$170M Sell
3,151,514
-117,271
-4% -$6.33M 0.13% 161
2024
Q1
$223M Sell
3,268,785
-100,977
-3% -$6.88M 0.15% 145
2023
Q4
$211M Sell
3,369,762
-95,708
-3% -$5.99M 0.16% 145
2023
Q3
$157M Sell
3,465,470
-67,887
-2% -$3.08M 0.13% 167
2023
Q2
$198M Sell
3,533,357
-439,823
-11% -$24.7M 0.15% 141
2023
Q1
$180M Sell
3,973,180
-33,296
-0.8% -$1.51M 0.13% 169
2022
Q4
$163M Sell
4,006,476
-256,260
-6% -$10.4M 0.13% 182
2022
Q3
$279M Sell
4,262,736
-321,362
-7% -$21M 0.23% 100
2022
Q2
$279M Sell
4,584,098
-35,649
-0.8% -$2.17M 0.21% 98
2022
Q1
$290M Buy
+4,619,747
New +$290M 0.19% 113